阿霉素的氧化还原生物学：氧化还原循环、拓扑异构酶抑制与氧化应激
Doxorubicin Redox Biology: Redox Cycling, Topoisomerase Inhibition, and Oxidative Stress.
作者信息
Zhu Hong, Sarkar Soumyadeep, Scott Laura, Danelisen Igor, Trush Michael A, Jia Zhenquan, Li Y Robert
机构信息
School of Osteopathic Medicine, Campbell University, Buies Creek, NC 27506, USA.
College of Pharmacy and Health Sciences, Campbell University, Buies Creek, NC 27506, USA.
出版信息
React Oxyg Species (Apex). 2016;1(3):189-198. doi: 10.20455/ros.2016.835.
Abstract
Doxorubicin (also called Adriamycin) is effective in treating a wide range of human cancers and currently considered as one of the most important drugs in cancer chemotherapeutics. The clinical use of doxorubicin is, however, associated with dosage-dependent cardiotoxicity and development of heart failure, which diminish the therapeutic index of this widely used anticancer drug. This article first surveys key research findings on doxorubicin redox biology that may impact its cardiotoxicity as well as anticancer activity. It then discusses emerging concepts, especially the topoisomerase IIb-p53-mitochondrion axis that may lead to the development of mechanistically based novel strategies to protect against cardiotoxicity and enhance the effectiveness of doxorubicin therapy.
摘要
阿霉素（也称为多柔比星）在治疗多种人类癌症方面有效，目前被认为是癌症化疗中最重要的药物之一。然而，阿霉素的临床应用与剂量依赖性心脏毒性和心力衰竭的发生有关，这降低了这种广泛使用的抗癌药物的治疗指数。本文首先综述了关于阿霉素氧化还原生物学的关键研究发现，这些发现可能会影响其心脏毒性以及抗癌活性。然后讨论了新出现的概念，特别是拓扑异构酶IIb-p53-线粒体轴，这可能会导致开发基于机制的新策略，以预防心脏毒性并提高阿霉素治疗的有效性。
相似文献
1
Doxorubicin Redox Biology: Redox Cycling, Topoisomerase Inhibition, and Oxidative Stress.
React Oxyg Species (Apex). 2016;1(3):189-198. doi: 10.20455/ros.2016.835.
2
Adriamycin-induced oxidative mitochondrial cardiotoxicity.
Cell Biol Toxicol. 2007 Jan;23(1):15-25. doi: 10.1007/s10565-006-0140-y. Epub 2006 Sep 28.
3
Teaching the basics of the mechanism of doxorubicin-induced cardiotoxicity: Have we been barking up the wrong tree?
Redox Biol. 2020 Jan;29:101394. doi: 10.1016/j.redox.2019.101394. Epub 2019 Nov 26.
4
Doxorubicin in vivo rapidly alters expression and translation of myocardial electron transport chain genes, leads to ATP loss and caspase 3 activation.
PLoS One. 2010 Sep 15;5(9):e12733. doi: 10.1371/journal.pone.0012733.
5
Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early Monitoring.
Mol Pharmacol. 2019 Aug;96(2):219-232. doi: 10.1124/mol.119.115725. Epub 2019 Jun 4.
6
Oxidative and non-oxidative mechanisms in the inactivation of cardiac mitochondrial electron transport chain components by doxorubicin.
Biochem J. 1989 Apr 1;259(1):181-9. doi: 10.1042/bj2590181.
7
Tissue-specific regulation of p53 by PKM2 is redox dependent and provides a therapeutic target for anthracycline-induced cardiotoxicity.
Sci Transl Med. 2019 Feb 6;11(478). doi: 10.1126/scitranslmed.aau8866.
8
Type IIB DNA topoisomerase is downregulated by trastuzumab and doxorubicin to synergize cardiotoxicity.
Oncotarget. 2017 Dec 21;9(5):6095-6108. doi: 10.18632/oncotarget.23543. eCollection 2018 Jan 19.
9
Cardioprotective Effects of Oroxylum indicum Extract Against Doxorubicin and Cyclophosphamide-Induced Cardiotoxicity.
Cardiovasc Toxicol. 2022 Jan;22(1):67-77. doi: 10.1007/s12012-021-09701-x. Epub 2021 Oct 8.
10
Identification of the molecular basis of doxorubicin-induced cardiotoxicity.
Nat Med. 2012 Nov;18(11):1639-42. doi: 10.1038/nm.2919. Epub 2012 Oct 28.
引用本文的文献
1
PNKP targeting engages the autophagic machinery through STING and STAT3 to potentiate ferroptosis and chemotherapy in TNBC.
Redox Biol. 2025 Jul 22;86:103775. doi: 10.1016/j.redox.2025.103775.
2
Mechanistic Insights into Flavonoid Subclasses as Cardioprotective Agents Against Doxorubicin-Induced Cardiotoxicity: A Comprehensive Review.
Drug Des Devel Ther. 2025 Jul 1;19:5553-5596. doi: 10.2147/DDDT.S535517. eCollection 2025.
3
Advances in Targeted Autophagy Modulation Strategies to Treat Cancer and Associated Treatment-Induced Cardiotoxicity.
Pharmaceuticals (Basel). 2025 May 1;18(5):671. doi: 10.3390/ph18050671.
4
Predictive Value of Gene Expression in Chemotherapy Response in Breast Cancer.
Pharmaceuticals (Basel). 2025 Feb 8;18(2):235. doi: 10.3390/ph18020235.
5
Novel Anthraquinone Derivatives and Their Complexes with Metal Ions with Anticancer Activity: Structure/Redox and Chelation Activity Correlations.
Pharmaceuticals (Basel). 2024 Dec 19;17(12):1717. doi: 10.3390/ph17121717.
6
Mechanisms of ferroptotic and non-ferroptotic organ toxicity of chemotherapy: protective and therapeutic effects of ginger, 6-gingerol and zingerone in preclinical studies.
Naunyn Schmiedebergs Arch Pharmacol. 2025 May;398(5):4747-4778. doi: 10.1007/s00210-024-03623-5. Epub 2024 Dec 5.
7
Present Scenario and Future Landscape of Payloads for ADCs: Focus on DNA-Interacting Agents.
Pharmaceuticals (Basel). 2024 Oct 7;17(10):1338. doi: 10.3390/ph17101338.
8
Complex Interplay between DNA Damage and Autophagy in Disease and Therapy.
Biomolecules. 2024 Jul 29;14(8):922. doi: 10.3390/biom14080922.
9
Metabolic reprogramming of poly(morpho)nuclear giant cells determines glioblastoma recovery from doxorubicin-induced stress.
J Transl Med. 2024 Aug 12;22(1):757. doi: 10.1186/s12967-024-05541-9.
10
A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging.
NPJ Aging. 2024 Jan 23;10(1):9. doi: 10.1038/s41514-024-00135-7.
本文引用的文献
1
Defining ROS in Biology and Medicine.
React Oxyg Species (Apex). 2016;1(1):9-21. doi: 10.20455/ros.2016.803.
2
Amelioration of inflammation and tissue damage in sickle cell model mice by Nrf2 activation.
Proc Natl Acad Sci U S A. 2015 Sep 29;112(39):12169-74. doi: 10.1073/pnas.1509158112. Epub 2015 Sep 14.
3
Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities.
J Am Coll Cardiol. 2014 Sep 2;64(9):938-45. doi: 10.1016/j.jacc.2014.06.1167.
4
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation.
J Clin Invest. 2014 Feb;124(2):617-30. doi: 10.1172/JCI72931. Epub 2014 Jan 2.
5
Keap1 redox-dependent regulation of doxorubicin-induced oxidative stress response in cardiac myoblasts.
Toxicol Appl Pharmacol. 2014 Jan 1;274(1):107-16. doi: 10.1016/j.taap.2013.10.023. Epub 2013 Nov 8.
6
Topoisomerase 2β: a promising molecular target for primary prevention of anthracycline-induced cardiotoxicity.
Clin Pharmacol Ther. 2014 Jan;95(1):45-52. doi: 10.1038/clpt.2013.201. Epub 2013 Oct 3.
7
Beyond oxidative stress: an immunologist's guide to reactive oxygen species.
Nat Rev Immunol. 2013 May;13(5):349-61. doi: 10.1038/nri3423.
8
New mechanistic and functional insights into DNA topoisomerases.
Annu Rev Biochem. 2013;82:139-70. doi: 10.1146/annurev-biochem-061809-100002. Epub 2013 Mar 13.
9
Identification of the molecular basis of doxorubicin-induced cardiotoxicity.
Nat Med. 2012 Nov;18(11):1639-42. doi: 10.1038/nm.2919. Epub 2012 Oct 28.
10
Targeting of Nrf2 induces DNA damage signaling and protects colonic epithelial cells from ionizing radiation.
Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):E2949-55. doi: 10.1073/pnas.1207718109. Epub 2012 Oct 8.
Zotero 插件